Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Otmar Pfister

Showing results (41-50 of 90) with videos related to

Pageof 9
Sort By:
Life Science Alliance|December 14, 2021
Fms-like tyrosine kinase 3 is a regulator of the cardiac side population in miceGiacomo Della Verde, Michika Mochizuki, Vera Lorenz, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention|March 13, 2023
A Comprehensive Secondary Prevention Benchmark (2PBM) Score Identifying Differences in Secondary Prevention Care in Patients After Acute Coronary SyndromeMatthias Haegele, Yu-Ching Liu, Simon Frey, et al.
Circulation Research|September 13, 2008
Role of the ATP-binding cassette transporter Abcg2 in the phenotype and function of cardiac side population cellsOtmar Pfister, Angelos Oikonomopoulos, Konstantina-Ioanna Sereti, et al.
European Journal of Heart Failure|March 16, 2017
Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF)Peter Rickenbacher, Beat A Kaufmann, Micha T Maeder, et al.
Journal of Clinical Medicine|December 11, 2022
Achievement of Low-Density Lipoprotein Cholesterol Targets in Cardiac Rehabilitation: Impact of the 2019 ESC/EAS Dyslipidaemia GuidelinesMatthias Haegele, Aleksandar Djurdjevic, Fabian Jordan, et al.
Journal of Hypertension|December 16, 2020
Hemodynamic profiles in treatment-naive arterial hypertension and their clinical implication for treatment choice: an exploratory post hoc analysisDelphine Glinz, Claudia Bläsi, Andrea Villiger, et al.
European Journal of Heart Failure|March 2, 2026
Incidence and management of heart failure phenotypes in patients undergoing transcatheter aortic valve implantationAnke von Peter, Thorald Stolte, Felix Goetzinger, et al.
Heart Rhythm|June 27, 2025
Use of guideline-directed medical heart failure therapy in patients with suspected arrhythmia-induced cardiomyopathyRebecca Arnet, Corinne Isenegger, Sven Knecht, et al.
JACC. Heart Failure|October 28, 2025
Undetected Heart Failure in Tertiary Care/Cardiology in SwitzerlandKlara Rumora, Christian Puelacher, Mirjam Pargger, et al.
European Heart Journal. Case Reports|September 12, 2022
Case report of elevation of high-sensitivity cardiac troponin T in the absence of cardiac involvement in immune checkpoint inhibitor-associated myositisFrancisco Javier Ruperti-Repilado, Jan Gerrit van der Stouwe, Philip Haaf, et al.
Pageof 9

Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
Life Science Alliance|December 14, 2021
Fms-like tyrosine kinase 3 is a regulator of the cardiac side population in miceGiacomo Della Verde, Michika Mochizuki, Vera Lorenz, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention|March 13, 2023
A Comprehensive Secondary Prevention Benchmark (2PBM) Score Identifying Differences in Secondary Prevention Care in Patients After Acute Coronary SyndromeMatthias Haegele, Yu-Ching Liu, Simon Frey, et al.
Circulation Research|September 13, 2008
Role of the ATP-binding cassette transporter Abcg2 in the phenotype and function of cardiac side population cellsOtmar Pfister, Angelos Oikonomopoulos, Konstantina-Ioanna Sereti, et al.
European Journal of Heart Failure|March 16, 2017
Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF)Peter Rickenbacher, Beat A Kaufmann, Micha T Maeder, et al.
Journal of Clinical Medicine|December 11, 2022
Achievement of Low-Density Lipoprotein Cholesterol Targets in Cardiac Rehabilitation: Impact of the 2019 ESC/EAS Dyslipidaemia GuidelinesMatthias Haegele, Aleksandar Djurdjevic, Fabian Jordan, et al.
Journal of Hypertension|December 16, 2020
Hemodynamic profiles in treatment-naive arterial hypertension and their clinical implication for treatment choice: an exploratory post hoc analysisDelphine Glinz, Claudia Bläsi, Andrea Villiger, et al.
European Journal of Heart Failure|March 2, 2026
Incidence and management of heart failure phenotypes in patients undergoing transcatheter aortic valve implantationAnke von Peter, Thorald Stolte, Felix Goetzinger, et al.
Heart Rhythm|June 27, 2025
Use of guideline-directed medical heart failure therapy in patients with suspected arrhythmia-induced cardiomyopathyRebecca Arnet, Corinne Isenegger, Sven Knecht, et al.
JACC. Heart Failure|October 28, 2025
Undetected Heart Failure in Tertiary Care/Cardiology in SwitzerlandKlara Rumora, Christian Puelacher, Mirjam Pargger, et al.
European Heart Journal. Case Reports|September 12, 2022
Case report of elevation of high-sensitivity cardiac troponin T in the absence of cardiac involvement in immune checkpoint inhibitor-associated myositisFrancisco Javier Ruperti-Repilado, Jan Gerrit van der Stouwe, Philip Haaf, et al.
Pageof 9